| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 15.42% on an annualized basis producing an average annual return of 28.56%. Currently, Novavax has a market capitalization of $2.34 billion.
Buying $100 In NVAX: If an investor had bought $100 of NVAX stock 5 years ago, it would be worth $345.87 today based on a price of $15.91 for NVAX at the time of writing.
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: NVAX
